Epinephrine exerts its effects on the heart through adrenergic receptors. Myocardial beta receptors have been considered to be one of the responsible receptors mediating the catecholamine-induced arrhythmias.l"4 Propranolol, a nonselective beta antagonist, l and 1-metoprolol, a selective beta I antagonist, 2 have been shown to prevent epinephrine-induced arrhythmia during halothane anaesthesia. Recent reports 5 have described the existence of both beta 1 and beta 2 adrenoceptors in the heart. 5-7 The effect of selective beta 2 antagonism on the genesis of the arrhythmias is controversial. Sharma, 3 using H 35/25 as a beta 2 antagonist, reported a weak protective effect against halothane-epinephrine arrhythmias and concluded that this action was attributed to its non-specific effect. On the other hand, we s examined the effect of a selective beta 2 antagonist, ICI-118,551, on the genesis of the arrhythmias provoked by various combinations of phenylephrine and isoproterenol, and showed that ICI-118,551 potentiated isoproterenol-induced arrhythmias in the presence of a low CAN J ANAESTH t992 / 39:8 / pp 873-6
Beta 2 as well as beta I adrenoceptors have been recognized in the heart of vertebrates. They mediate a positive chronotropic action of catecholamines. We compared the effect of selective beta I and beta 2 adrenoceptor antagonists on the genesis of halothaneepinephrine arrhythmias in dogs. The arrhythmogenic dose (AD) of epinephrine was increased in the presence of l-metoprolol, a selective beta I antagonist (8.40 _+ 1.13 izg 9 kg -1 9 min-l ; mean +-SEM), compared with control value (2.62 +--0.56) (P < 0.05). In contrast, ICI-118,551, a selective beta z antagonist, did not change the AD (2.36 --+ 0.43). Adding IC1-118,551 to l-metoprolol did not affect the AD of epinephrine in the presence of l-metoprolol alone
Epinephrine exerts its effects on the heart through adrenergic receptors. Myocardial beta receptors have been considered to be one of the responsible receptors mediating the catecholamine-induced arrhythmias.l"4 Propranolol, a nonselective beta antagonist, l and 1-metoprolol, a selective beta I antagonist, 2 have been shown to prevent epinephrine-induced arrhythmia during halothane anaesthesia. Recent reports 5 have described the existence of both beta 1 and beta 2 adrenoceptors in the heart. 5-7 The effect of selective beta 2 antagonism on the genesis of the arrhythmias is controversial. Sharma, 3 using H 35/25 as a beta 2 antagonist, reported a weak protective effect against halothane-epinephrine arrhythmias and concluded that this action was attributed to its non-specific effect. On the other hand, we s examined the effect of a selective beta 2 antagonist, ICI-118,551, on the genesis of the arrhythmias provoked by various combinations of phenylephrine and isoproterenol, and showed that ICI-118,551 potentiated isoproterenol-induced arrhythmias in the presence of a low CAN J ANAESTH t992 / 39:8 / pp 873-6 dose of phenylephrine. The inconsistent results may be because different drugs produce different activation of myocardial adrenergic receptors. Thus, the present study was designed as an extension of our previous work, to compare the effects of beta! and beta 2 antagonism on the epinephrine-induced arrhythmias during halothane anaesthesia.
Methods
The studies were conducted under guidelines approved by the Animal Care Committee of Osaka University Medical School.
Thirty-nine adult mongrel dogs of either sex and weighing 8-11.5 kg were used in the study. Anaesthesia was induced with halothane alone and maintained at an end-tidal concentration of 1.3%, which was monitored continuously by an anaesthetic gas analyzer (Datex AA 102-30-00, Helsinki, Finland). The trachea of each dog was intubated with a cuffed tracheal tube, and the lungs were mechanically ventilated with air (Aika R60, Tokyo, Japan). The PETCO 2 was monitored continuously with an expired gas monitor (Minato 1H 21A, Osaka, Japan) and maintained at 35--40 mmHg. A heating lamp and a circulating water blanket were used to maintain nasal temperature between 37.0 and 38.5 ~ C. Lead II of the ECG was monitored continuously. A femoral artery catheter was inserted for both pressure monitoring and blood sampling. A femoral vein was cannulated for the administration of both epinephrine and a solution of lactated Ringer's solution, infused at a rate of 10 ml. kg -~. hr -~. Serum K* concentration was maintained between 3.5 and 4.5 mEq. L -l by infusion of K § at a rate of 1-10 mEq. hr -1. Arterial pH, PO2, and serum Na + concentration were maintained within the range of 7.35-7.45, 85-95 mmHg, and 135-150 mEq. L -1, respectively.
The drugs used in the present study were 1-metoprolol as a selective beta~ antagonist, 9 d-metoprolol, a stereoisomer of l-metoprolol which has membrane stabilization effect but lacks beta I antagonistic effect, and ICI-118,551 a selective beta 2 antagonist, l~
The arrhythmia threshold was achieved when four or more premature ventricular contractions occurred within 15 sec. The arrhythmogenic dose (AD) of epinephrine was defined as the lowest dose that achieved the arrhythmia threshold, as previously reported.l i The AD of epinephrine was determined in each dog with standardized logarithmica)ly spaced infusions of epinephrine lasting three minutes with 10-30 rain recovery periods between infusions. The infusion was started at the minimum dose of 0.67 ~g-kg -l. min -I and the dose was increased by e ~ (e = 2.72) until arrhythmias occurred. If arrhythmias did occur at one of these doses, a smaller dose, divided by e ~ was tested. The AD of epinephrine was determined under five different conditions: in the presence of 1-metoprolol (0.4 mg. kg-I); d-metoprolol (0.4 mg. kg-1; ICI-118,551 (0.2 mg. kg-1); and both 1-metoprolol and ICI-118,551; or with no antagonist (control). A 4 ml arterial blood sample was collected to allow measurement of arrhythmogenic plasma concentration (APC) of epinephrine at the time when the criterion for the AD had been satisfied. Plasma epinephrine was determined in a fully automated high-performance liquid chromatography-fluorometric system (model HLC-8030 Catecholamine Analyzer, Tosoh, Tokyo, Japan) using a diphenylethylenediamine condensation method. 12 This assay method has a limit of sensitivity of 10 pg. ml -l for epinephrine. The inter-and intra-assay variations are less than 3%. As there was individual variability in both the AD and APC values, the mean AD and APC values were calculated.
Data are expressed as mean __+ SEM. The results of multiple groups were analyzed by one-way analysis of variance, and comparison between groups was assessed by Scheffe's test. P < 0.05 was considered statistically significant.
Results
The AD and APC of epinephrine in the presence of various beta antagonists are shown in Figures 1 and 2 , respectively. L-metoprolol prevented epinephrine-induced arrhythmias and increased the arrhythmia threshold to 3.2-fold of the control level (P < 0.05), whereas ICI-118,551 did not produce any change in AD and APC. The effect of d-metoprolol was not also statistically significant. The combined administration of l-metoprolol and ICI-118,551 increased both AD and APC of epinephrine significantly, but the antiarrhythmic effect of combination of l-metoprolol and ICI-118,551 was not different from that of l-metoprolol alone. Systolic and diastolic arterial pressure and heart rate at the time of the arrhythmias induced by epinephrine in the presence of various antagonists are shown in the Table. Systolic arterial pressure and heart rate did not vary in the presence of various antagonists, whereas diastolic arterial pressure in the presence of 1-metoprolol plus ICI-118,551 was higher than that in control. 
Discussion
Application of new selective adrenoceptor agonists and antagonists has contributed to knowledge of the adrenoceptor mechanism involved in epinephrine-induced arrhythmias. ~3 It has been reported recently that beta 2 adrenoceptors are present in the hearts of vertebrates 6'7 and are classified as relatively epinephrine-selective compared with norepinephrine. 14 Therefore, the role of beta 2 adrenoceptors in the genesis of halothane-epinephrine arrhythmias should be evaluated. The present results show that beta I blockade by 1-metoprolol increased AD and APC of epinephrine, whereas beta 2 blockade by ICIo I 18,551 did not prevent the epinephrine-induced arrhythmia (Figures  1, 2) . Furthermore, ICI-118,551, when added to lmetoprolol, did not produce any change in the AD and APC of epinephrine compared with l-metoprolol alone (Figures 1, 2) . Therefore, beta 2 blockade would be of no use in opposing halothane-epinephrine arrhythmias. Sharma 3 reported that H 35/25, a selective beta 2 antagonist, prevented epinephrine-induced arrhythmias in halothane anaesthetized dogs to some degree. He attributed its inhibitory effect to the nonspecific action. Although our present findings seem to be contrary to his study, 3 and despite similar experimental models, this discrepancy may be due to a difference in beta 2 selectivity between the two antagonists used. 10,15 ICI-118,551 is considered to have a higher degree of beta2 selectivity and the dose of ICI-118,551, 0.2 mg.kg-~ used in the present study was reported to be adequate to block beta 2 adrenoceptors selectively in dogs. 16 On the other hand, the dose of H 35/25 in Sharrna's previous report appeared to be so great that a non-specific effect was involved in its antiarrhythmic activity. 3 Therefore, the results of the two studies may be compatible as regards the ineffectiveness of beta 2 adrenoceptor antagonism.
Membrane stabilization as well as beta 2 blockade could be involved in the effect of 1-metoprolol. 17 It is well known that beta2-receptors exist on vascular smooth muscle and they exert a vasodilating effect. 5'7 Inhibition of these receptors might enhance the epinephrine-induced arterial pressure elevation resulting in potentiation of its arrhythmogenicity, s However, in the present study systolic arterial pressures in each group were not different. Therefore, the effect of beta 2 antagonist was not involved in the modulation of myocardial sensitization by halothane.
Finally, the vulnerability to myocardial sensitization by halothane would vary between dogs and humans because of a species difference. Is Thus we would like to address limited applicability of the present results to the clinical settings.
In conclusion, beta 2 sympathetic antagonism did not contribute to the prevention of the epinephrine-induced arrhythmias during halothane anaesthesia as did the beta 1 antagonist, l-metoprolol. Therefore, selective beta I antagonists are recommended for the treatment of halothaneepinephrine arrhythmias rather than nonselective beta antagonists, such as propranolol.
